Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1211539.RANvj2xgm7FFCxpdMDBrg6X3bqYk_pJtG9Vq0WiTVBoZM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1211539.RANvj2xgm7FFCxpdMDBrg6X3bqYk_pJtG9Vq0WiTVBoZM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1211539.RANvj2xgm7FFCxpdMDBrg6X3bqYk_pJtG9Vq0WiTVBoZM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1211539.RANvj2xgm7FFCxpdMDBrg6X3bqYk_pJtG9Vq0WiTVBoZM130_provenance.
- NP1211539.RANvj2xgm7FFCxpdMDBrg6X3bqYk_pJtG9Vq0WiTVBoZM130_assertion description "[Taken together, these data strongly suggest that BRCA1-IRIS and/or BDNF/TrkB and NRG1/ErbB2 could serve as rational therapeutic targets for advanced ovarian cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1211539.RANvj2xgm7FFCxpdMDBrg6X3bqYk_pJtG9Vq0WiTVBoZM130_provenance.
- NP1211539.RANvj2xgm7FFCxpdMDBrg6X3bqYk_pJtG9Vq0WiTVBoZM130_assertion evidence source_evidence_literature NP1211539.RANvj2xgm7FFCxpdMDBrg6X3bqYk_pJtG9Vq0WiTVBoZM130_provenance.
- NP1211539.RANvj2xgm7FFCxpdMDBrg6X3bqYk_pJtG9Vq0WiTVBoZM130_assertion SIO_000772 25132263 NP1211539.RANvj2xgm7FFCxpdMDBrg6X3bqYk_pJtG9Vq0WiTVBoZM130_provenance.
- NP1211539.RANvj2xgm7FFCxpdMDBrg6X3bqYk_pJtG9Vq0WiTVBoZM130_assertion wasDerivedFrom befree-2016 NP1211539.RANvj2xgm7FFCxpdMDBrg6X3bqYk_pJtG9Vq0WiTVBoZM130_provenance.
- NP1211539.RANvj2xgm7FFCxpdMDBrg6X3bqYk_pJtG9Vq0WiTVBoZM130_assertion wasGeneratedBy ECO_0000203 NP1211539.RANvj2xgm7FFCxpdMDBrg6X3bqYk_pJtG9Vq0WiTVBoZM130_provenance.
- befree-2016 importedOn "2016-02-19" NP1211539.RANvj2xgm7FFCxpdMDBrg6X3bqYk_pJtG9Vq0WiTVBoZM130_provenance.